López-Simarro F, Redondo Margüello E, Mediavilla Bravo J J, Soriano Llora T, Iturralde Iriso J, Hormigo Pozo A
Área Básica de Salud Martorell Urbano, Institut Català de la Salut, Martorell, Barcelona, España; Grupo de Trabajo Diabetes de SEMERGEN, España.
Centro de Salud Internacional Madrid Salud, Ayuntamiento de Madrid, Madrid, España; Grupo de Actividades Preventivas y Salud Pública de SEMERGEN, España.
Semergen. 2019 Mar;45(2):117-127. doi: 10.1016/j.semerg.2018.07.007. Epub 2018 Dec 20.
The bidirectional relationship between infectious diseases and diabetes is well-known. On the one hand, diabetes patients are at a higher risk of presenting with infectious diseases, possibly with more severity, and on the other hand, infectious diseases impair metabolic control in patients with diabetes. Population ageing arises partly due to an increased survival rate in chronic diseases, of which diabetes is amongst them. Improving infectious disease prevention could reduce complications arising from the former diseases, consequences of decompensated diabetes condition (morbidity, incapacity, hospital admissions, healthcare costs, and mortality rates) and result in improved quality of life in patients with diabetes. The current review presents the treatment of infectious diseases in patients with diabetes and the dealing with immuno-preventable diseases with the currently advised vaccinations.
